A first in man, phase I dose-escalation study of PHA-793887, an inhibitor of multiple cyclin-dependent kinases (CDK2, 1 and 4) reveals unexpected hepatotoxicity in patients with solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A first in man, phase I dose-escalation study of PHA-793887, an inhibitor of multiple cyclin-dependent kinases (CDK2, 1 and 4) reveals unexpected hepatotoxicity in patients with solid tumors

Published:2011-03-15 Issue:6 Volume:10 Page:963-970
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Massard Christophe,Soria Jean-Charles,Anthoney D. Alan,Proctor A.,Scaburri Angela,Pacciarini Maria Adele,Laffranchi Bernard,Pellizzoni Cinzia,Kroemer Guido,Armand Jean-Pierre,Balheda Rastilav,Twelves Christopher J.

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.10.6.15075

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets;Cancers;2024-02-23

2. Seize the engine: Emerging cell cycle targets in breast cancer;Clinical and Translational Medicine;2024-01

3. A precise prognostic signature in CTNNB1-mutant hepatocellular carcinoma: Prognosis prediction and precision treatment exploration;Heliyon;2023-12

4. Three candidate anticancer drugs were repositioned by integrative analysis of the transcriptomes of species with different regenerative abilities after injury;Computational Biology and Chemistry;2023-10

5. An Overview of CDK Enzyme Inhibitors in Cancer Therapy;Current Cancer Drug Targets;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP